In men with hormone-sensitive metachronous oligometastatic prostate cancer, the use of stereotactic body radiotherapy (SBRT) commonly delayed the need for long-term ADT and provided durable disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback